Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-09 | 2024-03 | -0.21 | N/A | N/A | N/A |
2024-03-14 | 2023-12 | 0 | -0.5 | N/A | N/A |
2023-11-09 | 2023-09 | -0.29 | -0.2 | 0.09 | 31.03% |
2023-11-09 | 2023-09 | -0.29 | N/A | N/A | N/A |
2023-08-10 | 2023-06 | -0.24 | -0.31 | -0.07 | -29.17% |
2023-08-10 | 2023-06 | -0.24 | N/A | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-13 | HC Wainwright & Co. | Upgrade | Neutral | Neutral |
2023-05-14 | HC Wainwright & Co. | Upgrade | Neutral | Neutral |
2023-03-19 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
2023-02-22 | HC Wainwright & Co. | Upgrade | Buy | |
2022-11-13 | HC Wainwright & Co. | Upgrade | Buy | |
2022-08-14 | HC Wainwright & Co. | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2021-05-23 | BENSON REED L | General Counsel | 3.17K | Conversion of Exercise of derivative security |
2023-11-21 | BROWN BRIAN LEE | Chief Financial Officer | 213.22K | Stock Award(Grant) |
2023-11-21 | DURENARD EUGENE A | Director | 85.00K | Stock Award(Grant) |
2023-11-21 | EGAN DWIGHT H | Chief Executive Officer | 270.88K | Stock Award(Grant) |
2023-11-21 | MURPHY TED | Director | 97.50K | Stock Award(Grant) |
2023-11-21 | NELSON JAMES B | Director | 85.00K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 1.78M | 1.98M | 5.79% |
2023-06-29 | Renaissance Technologies, LLC | 653.70K | 725.61K | 2.12% |
2023-06-29 | Blackrock Inc. | 506.51K | 562.22K | 1.65% |
2023-06-29 | Geode Capital Management, LLC | 302.16K | 335.39K | 0.98% |
2023-06-29 | Bridgeway Capital Management, Inc. | 272.90K | 302.92K | 0.89% |
2023-06-29 | Bank Of New York Mellon Corporation | 145.62K | 161.64K | 0.47% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 1.28M | 1.42M | 4.15% |
2023-06-29 | Vanguard Extended Market Index Fund | 444.78K | 493.70K | 1.44% |
2023-06-29 | Bridgeway Funds Inc-Ultra Small Company Fund | 272.90K | 302.92K | 0.89% |
2023-05-30 | Fidelity Extended Market Index Fund | 165.22K | 180.09K | 0.54% |
2023-08-30 | iShares Micro Cap ETF | 69.84K | 86.60K | 0.23% |
2023-05-30 | Fidelity Total Market Index Fund | 53.59K | 58.41K | 0.17% |
-
-
-
-
$CODX - To all long holders including me, what you see today is technically MA50 resistance. Once the price will cross over it, there will be no short cause they will all be died.
-
$CODX - celebrations above 15.54
-
15 show your face!!
-
$CODX - LETS GO TO 15!!!!!!
-
$CODX - more and more testing equals to more revenue. Looking into their inventories reported, it has huge opportunities.
-
$CODX - Definitely heading for daily recovery , amazing
-
$CODX -has to stabilize above 14
-
$CODX - undervalued company
-
$CODX - My chart , enjoy
https://twitter.com/shmulic12/status/1310655955713941504?s=21
-
$CODX - very strong momentum, although we see some red sometimes. Whoever is long here can stay calm as long stock price remains above 13.
-
$CODX - Bullish flag pattern 1h chart , target above 16. Good luck
-
$CODX - I WARN THE BEARS! Published a 1h chart! There is a nice uptrend line ! Good for the bulls
-
$CODX - Shorts are working hard for nothing. Keep in mind that more COVID cases, better incomes and growth.
-
Co-Diagnostics, Inc. (CODX) Q4 2023 Earnings Call Transcript
seekingalpha.com • -
Co-Diagnostics, Inc. (CODX) Q3 2023 Earnings Call Transcript
seekingalpha.com • -
Co-Diagnostics, Inc. (CODX) Q1 2023 Earnings Call Transcript
seekingalpha.com • -
Co-Diagnostics, Inc. (CODX) Q4 2022 Earnings Call Transcript
seekingalpha.com • -
Co-Diagnostics, Inc. (CODX) Q3 2022 Earnings Call Transcript
seekingalpha.com • -
7 Vaccine Stocks to Sell ASAP Now That the ‘Pandemic's Over'
investorplace.com • -
Why Co-Diagnostics Stock Slipped Today
fool.com • -
Co-Diagnostics set to expand OEM deal with Bio Molecular Systems at AACC expo
proactiveinvestors.com • -
CODX Stock Pops as Co-Diagnostics Ships Out Monkeypox Tests
investorplace.com • -
Why Co-Diagnostics Stock Is Rising Today
fool.com • -
Why Co-Diagnostics Is Running Higher Today
fool.com • -
Co-Diagnostics develops principal design work on monkeypox PCR test
proactiveinvestors.com • -
Why Co-Diagnostics Stock Is Trading Higher After Hours
benzinga.com • -
Co-Diagnostics adds four new experts to its Scientific Advisory Board
proactiveinvestors.com • -
Why Co-Diagnostics Is Soaring Today
fool.com • -
Why Co-Diagnostics Shares Are Trading Higher Today
benzinga.com • -
Co-Diagnostics: Swinging For The Fences
seekingalpha.com • -
4 Stocks With High Growth Potential
gurufocus.com • -
7 Stocks to Buy to Hedge Against Omicron Variant Risks
investorplace.com • -
Co-Diagnostics partners with TiiCKER to increase connection with retail investors
proactiveinvestors.com • -
Co-Diagnostics sees record 3Q revenue of $30.1M on Logix Smart coronavirus test sales
proactiveinvestors.com • -
Co-Diagnostics says its Logix Smart COVID-19 test has been approved for sale in the UK
proactiveinvestors.com • -
Co-Diagnostics fighting coronavirus (COVID-19) with flagship test, plans at-home PCR-based platform
proactiveinvestors.com • -
Co-Diagnostics announces corporate rebranding after period of transformative growth and expansion
proactiveinvestors.com • -
Co-Diagnostics says its Logix Smart ABC Test is authorized for use in Mexico
proactiveinvestors.com • -
Why Co-Diagnostics Is A Solid Covid-19 Play
seekingalpha.com • -
Co-Diagnostics sees 2Q revenue rise by 13.8% driven by sales of the Logix Smart COVID-19 Test
proactiveinvestors.com • -
Why Co-Diagnostics Shares Are Skyrocketing Today
benzinga.com •